Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prothrombotic genotypes and risk of venous thromboembolism in cancer.

Thrombosis research - 1 Apr 2018

Gran Olga V, Brækkan Sigrid K, Hansen John-Bjarne

Abstract excerpt

Venous thromboembolism (VTE) is a common and potentially life-threatening complication in cancer. Patients with cancer are at a higher risk of VTE-related complications such as major bleeding during anticoagulant treatment, recurrence and mortality. Therefore, it is important to identify cancer patients with high risk of VTE in order to implement targeted prevention to those with a favorable benefit-to-harm ratio...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ABO gene
Share to Genotype
Share to Neoplasms

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Risk Factors

Share to Venous Thromboembolism

Source

Identifiers

PMID: 29703469
DOI: 10.1016/j.thromres.2017.12.025

Genes

ABO

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prothrombotic genotypes and risk of venous thromboembolism in cancer.PMID 29703469Read ↗

Prothrombotic genotypes and risk of venous thromboembolism in occult cancer.Semantic proximity Read ↗

Inherited thrombophilia gene mutations and risk of venous thromboembolism in patients with cancer: A systematic review and meta-analysis.Semantic proximity Read ↗

Combined effects of five prothrombotic genotypes and cancer on the risk of a first venous thromboembolic event.Semantic proximity Read ↗

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.Semantic proximity Read ↗

Polymorphisms of the coagulation system and risk of cancer.Semantic proximity Read ↗

Factor V Leiden, prothrombin 20210A and the risk of venous thrombosis among cancer patients.Semantic proximity Read ↗

Prothrombotic genotypes and risk of major bleeding in patients with incident venous thromboembolism.Semantic proximity Read ↗

Genetic risk factors for venous thromboembolism.Semantic proximity Read ↗

Do thrombophilic gene mutations have a role on thromboembolic events in cancer patients?Semantic proximity Read ↗

The role of germline and somatic mutations in predicting cancer-associated thrombosis: a narrative review.Semantic proximity Read ↗

Malignancies, prothrombotic mutations, and the risk of venous thrombosis.Semantic proximity Read ↗

Factor V Leiden mutation increases the risk for venous thromboembolism in cancer patients - results from the Vienna Cancer And Thrombosis Study (CATS).Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.